In addition, the same study showed that only cholangiocarcinoma, DLBC, and KIRP cases with genetic alteration had copy number deletion of YY1, while the “amplification” type of CNVs was only seen in adrenocortical carcinoma and pheochromocytoma/paraganglioma tumors [52]. This evidence concerns the gene YY1 and adrenal cortex carcinoma.